Log in
Enquire now
Palleon Pharmaceuticals

Palleon Pharmaceuticals

Palleon Pharmaceuticals is a glycoimmune Checkpoint Inhibitors founded in 2016.

OverviewStructured DataIssuesContributors

Contents

palleonpharma.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Immunotherapy
Immunotherapy
Biomedical engineering
Biomedical engineering
Technology
Technology
Cancer
Cancer
Oncology
Oncology
Biology
Biology
Biotechnology
Biotechnology
...
Location
Waltham, Massachusetts
Waltham, Massachusetts
United States
United States
B2X
B2B
B2B
0
Pitchbook URL
pitchbook.com/profiles...162273-88
Number of Employees (Ranges)
11 – 50
Full Address
266 Second Ave, Waltham, Massachusetts 02451, US
Investors
SR One
SR One
AbbVie Ventures
AbbVie Ventures
Vertex Ventures HC
Vertex Ventures HC
Surveyor Capital
Surveyor Capital
Takeda Ventures
Takeda Ventures
Matrix Capital Management
Matrix Capital Management
Pfizer Venture Investments
Pfizer Venture Investments
Founded Date
2016
Total Funding Amount (USD)
147,600,000
Latest Funding Round Date
September 2020
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
100,000,000
Public/Private
Private
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Palleon Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.